Centro de Investigaciones Clínicas Vina del Mar

Viña del Mar 2540364

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Renal Cell Carcinoma, Primary Biliary Cholangitis, Renal Cell Carcinoma

Studies at this site

• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed